Clinical trial
Phase 1 Study of the Pancreatic Breath Test to Detect Early Stage Chronic Pancreatitis Utilizing the Secretin Stimulation Test
NCT01184573 is registered in ClinicalTrials.gov with Metabolic Solutions Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of the Pancreatic Breath Test to Detect Early Stage Chronic Pancreatitis Utilizing the Secretin Stimulation Test
- Lead sponsor
- Metabolic Solutions Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- September 30, 2012
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pancreatitis